• VitalHub (VHI) has acquired UK-based S12 Solutions
  • S12 Solutions is a digital platform helping professionals complete the UK’s Mental Health Act 1983 processes
  • S12 Solutions has a recurring revenue base of C$2,617,000
  • This is VitalHub’s 10th acquisition since 2017
  • VitalHub is down 3.00 per cent on the day, with shares trading at $2.91 at 3:33 pm ET

VitalHub (VHI) has acquired UK-based S12 Solutions.

S12 Solutions helps mental health professionals complete the UK’s Mental Health Act 1983 processes.

S12 Solutions is a digital platform, which connects Approved Mental Health Professionals (AMHP) with approved section 12 doctors for MHA assessments in England. Health professionals are able to find available, local doctors, create s.12 doctor claims, and both AMHPs and doctors can create, complete and share electronic statutory MHA forms.

S12 Solutions has a recurring revenue base of C$2,617,000 which represents almost all of its revenue and adds to VitalHub’s growing Annualized Contract Value (ACV).

VitalHub’s ACV, including the company’s recently-announced acquisition of selected assets of Jayex Healthcare and the acquisition of S12 Solutions, now stands at $18,187,000.

This is VitalHub’s 10th acquisition since 2017 and marks the company’s continued expansion into the growing mental health patient-care sector.

“S12 is a powerful platform with enormous potential, addressing the remarkable need for health and social care systems to work together and gain access to registered professionals for urgent and time sensitive assessments of patients.

The need to locate professionals during crisis situations continues to be an important factor in ensuring patients in need are supported by professionals best suited to their needs. S12 Solutions has developed a platform that enables best-in-class response, built with tremendous vision and understanding, resulting in a better solution than what currently exists.

With VitalHub’s significant infrastructure and global footprint, we see a tremendous opportunity to leverage this technology, both in its application surrounding mental health and toward disrupting other market verticals where we believe this technology can be impactful,” said VitalHub Corp. CEO Dan Matlow.

VitalHub is down 3.00 per cent on the day, with shares trading at $2.91 at 3:33 pm ET.

More From The Market Online
The Market Online Video

Emerging opportunity in a growing, high-value dermatological market

Kane Biotech (TSXV:KNE) engages in the development and commercialization of products that prevent and remove microbial biofilms.

Cannabis stock jumps on news its products are coming to Canada

Ovation Science Inc. (CSE:OVAT) signs an exclusive licensing agreement for its products in Canada with Ripco Processing Inc.